1 December 2008 in The American Journal of Clinical Nutrition
Background: Changes in serum 25-hydroxyvitamin D [25(OH)D] concentrations in the US population have not been described.Objective: We used data from t
18 March 2017 in Osteoporosis International
1 January 2008 in Journal of Bone and Mineral Research
We used serum 25(OH)D data from NHANES III and incident hip fracture cases identified using linked mortality and Medicare records, and found that serum 25(OH)D was significantly related to reduced hip fracture risk in non-Hispanic white adults ≥65 yr of age. Introduction: The role of vitamin D status in reducing fracture risk is unclear. We examined the relationship between serum 25 hydroxyvitamin D [25(OH)D] and incident hip fracture risk in older non-Hispanic white adults. Materials and Methods: The study sample consisted of 1917 white men and women ≥65 yr of age who were examined in the third National Health and Nutrition Examination Survey (NHANES III, 1988-1994), a nationally representative survey. Incident hip fractures were ascertained using linked mortality and Medicare records that were obtained for NHANES III participants. Serum 25(OH)D values were measured with a radioimmunoassay kit. Cox proportional hazards models were used to estimate the relative risk (RR) of hip fracture by serum 25(OH)D level. Results: There were 156 incident hip fracture cases in the sample. Cases were older, had lower BMD and body mass index, more prevalent spine or wrist fractures and weight loss before baseline, and ate fewer kilocalories and less calcium than noncases. After adjusting for these differences, serum 25(OH)D values exceeding 60 nM were significantly related to hip fracture risk. For example, the multivariate-adjusted RR was 0.64 (95% CI, 0.46-0.89) among individuals with serum 25(OH)D values ≥62.5 nM compared with those with values below this level. When grouped into quartiles, the multivariate-adjusted RR for the second, third, and fourth versus the first quartile of serum 25(OH)D were 0.50 (95% CI, 0.25-1.00), 0.41 (95% CI, 0.24-0.70), and 0.50 (95% CI, 0.29-0.86), respectively. Conclusions: Serum 25(OH)D was related to a significantly lower hip fracture risk in this cohort of older white adults, even after adjusting for several relevant confounding variables. The relationship did not seem to be linear across all values. Our results support other studies suggesting that serum 25(OH)D values exceeding 60 nM are associated with health benefits.
1 February 2005 in The Journal of Clinical Endocrinology & Metabolism
Obesity has been linked to lower serum 25-hydroxyvitamin D [25(OH)D] values, but whether this relationship plays a role in the poorer vitamin D status observed in blacks vs. whites is not clear. This study examines the relationship between serum 25(OH)D and percent body fat (%BF) by race in 6042 women (3567 non-Hispanic whites and 2475 non-Hispanic blacks), aged 12+ yr, from the third National Health and Nutrition Examination Survey (NHANES III, 1988–1994). Serum 25(OH)D values were measured with an RIA kit (DiaSorin), and %BF was calculated from bioelectrical impedance analysis. Adjusting for %BF only slightly reduced differences in mean serum 25(OH)D by race. The negative relationship between serum 25(OH)D and %BF was noticeably stronger in whites than in blacks of the same age. Within race, the relationship was stronger in younger than older individuals. Adjusting for confounders reduced, but did not remove, these differences in relationship strength. In conclusion, the serum 25(OH)D-%BF relationship in women varies both by race (stronger in whites than blacks) and age (stronger in younger than older persons). This complex relationship may explain why differences in obesity do not appear to play a major role in explaining variation in serum 25(OH)D by race.
1 December 2020 in Journal of Bone and Mineral Research
Hip fracture incidence appears to be declining in the United States, but changes in bone mineral density (BMD) of the population have not been evaluated. We used femur BMD data from the National Health and Nutrition Examination Survey (NHANES) 2005–2006 to estimate the prevalence of low femoral BMD in adults age 50 years and older and compared it with estimates from NHANES III (1988–1994). Dual-energy X-ray absorptiometry systems (pencil-beam geometry in NHANES III, fan-beam geometry in NHANES 2005–2006) were used to measure femur BMD, and World Health Organization (WHO) definitions of low BMD were used to categorize skeletal status. In 2005–2006, 49% of older US women had osteopenia and 10% had osteoporosis at the femur neck. In men, 30% had femur neck osteopenia and 2% had femur neck osteoporosis. An estimated 5.3 million older men and women had osteoporosis at the femur neck, and 34.5 million more had osteopenia in 2005–2006. When compared with NHANES III, the age-adjusted prevalence of femur neck osteoporosis in NHANES 2005–2006 was lower in men (by 3 percentage units) and women (by 7 percentage units) overall and among non-Hispanic whites. Changes in body mass index or osteoporosis medication use between surveys did not fully explain the decline in osteoporosis. Owing to the increase in the number of older adults in the US population, however, more older adults had low femur neck BMD (osteoporosis + osteopenia) in 2005–2006 than in 1988–1994. Thus, despite the decline in prevalence, the estimated number of affected older adults in 2005–2006 remained high. Copyright © 2010 American Society for Bone and Mineral Research